Authors: Gow, JW Simpson, K Behan, PO Chaudhuri, A McKay, IC Behan, WMH

Citation: Jw. Gow et al., Antiviral pathway activation in patients with chronic fatigue syndrome andacute infection, CLIN INF D, 33(12), 2001, pp. 2080-2081

Authors: Stone, TW Behan, WMH MacDonald, M Darlington, LG

Citation: Tw. Stone et al., Possible mediation of quinolinic acid-induced hippocampal damage by reactive oxygen species, AMINO ACIDS, 19(1), 2000, pp. 275-281

Authors: Behan, WMH Madigan, M Clark, BJ Goldberg, J McLellan, DR

Citation: Wmh. Behan et al., Muscle changes in the neuroleptic malignant syndrome, J CLIN PATH, 53(3), 2000, pp. 223-227

Authors: Behan, WMH Stone, TW

Citation: Wmh. Behan et Tw. Stone, Role of kynurenines in the neurotoxic actions of kainic acid, BR J PHARM, 129(8), 2000, pp. 1764-1770

Authors: Paul, L Wood, L Behan, WMH Maclaren, WM

Citation: L. Paul et al., Demonstration of delayed recovery from fatiguing exercise in chronic fatigue syndrome, EUR J NEUR, 6(1), 1999, pp. 63-69

Authors: Behan, WMH McDonald, M Darlington, LG Stone, TW

Citation: Wmh. Behan et al., Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl, BR J PHARM, 128(8), 1999, pp. 1754-1760